TY - JOUR T1 - It's time to evolve from Scadding: phenotyping sarcoidosis JF - European Respiratory Journal JO - Eur Respir J DO - 10.1183/13993003.00050-2018 VL - 51 IS - 1 SP - 1800050 AU - Daniel A. Culver AU - Robert P. Baughman Y1 - 2018/01/01 UR - http://erj.ersjournals.com/content/51/1/1800050.abstract N2 - Sarcoidosis is complex and highly variable, with protean clinical manifestations and a wide array of consequences for patients. The course is likewise unpredictable, leading to the moniker “sarcoidoses” to connote that sarcoidosis may be a syndrome rather than a single disease [1]. Delineating distinct subgroups, “phenotypes”, has been an attempt to simplify prediction about individual patients and to homogenise groups for research purposes. Sarcoidosis phenotypes have been used most often to predict prognosis or to cluster patients with similar outcomes [2–5]. But phenotyping could also be used primarily to stratify patients by clinical features such as extent of organ involvement, or by perceived severity [6, 7].Novel approaches to cluster sarcoidosis by organ clusters may yield new clinical and pathophysiologic insights http://ow.ly/uCVG30hMsro ER -